[Recommendations for use of rituximab in patients with rheumatoid arthritis]
- PMID: 24659153
- DOI: 10.1007/s00393-013-1238-2
[Recommendations for use of rituximab in patients with rheumatoid arthritis]
Abstract
Treatment with rituximab (RTX) has been approved since 2006 for patients with rheumatoid arthritis who previously failed to respond to tumor necrosis factor (TNF) inhibitor therapy or who experienced side effects. In these updated treatment recommendations new data relating to evaluation of the therapeutic response, retreatment, the role of predictive factors as well as safety data are incorporated and discussed.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
